CDKN1A and colorectal carcinoma: In CRC cells, PADI can promote the migration and growth of GSK3β by promoting the nuclear transport of nuclear cyclin-dependent kinase inhibitor 1 (CDKN1A) ubiquitin-dependent proteasome degradation (186).